oxophenylarsine has been researched along with Kaposi Sarcoma in 1 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, Z | 1 |
| Cavallaro, U | 1 |
| Marchisio, PC | 1 |
| Soria, MR | 1 |
| Maier, JA | 1 |
1 other study available for oxophenylarsine and Kaposi Sarcoma
| Article | Year |
|---|---|
Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation.
Topics: Animals; Antigens, CD; Arsenicals; Blotting, Western; Cell Division; Dose-Response Relationship, Dru | 1998 |